Home > NEWS
REMDESIVIR(Most effective drug for Covid-19) suppier---SENOVA
release time:2020-09-01

Product name:Remdesivir                   Cas No.:1809249-37-3

Molecular Formula:C27H35N6O8P     Molecular Weight:602.575961


Today, as part of its ongoing efforts to fight COVID-19, the U.S. Food and Drug Administration broadened the scope 

of the existing emergency use authorization (EUA) for the drug Veklury (remdesivir) to include treatment of all 

hospitalized adult and pediatric patients with suspected or laboratory-confirmed COVID-19, irrespective of their 

severity of disease. 


From the beginning of this year, SENOVA has been deploying Remdesivir API to Anti-COVID-19 pandemic.

The capacity of REMDESIVIR API is about 100kg/month with facility GMP and DMF.

Headquarter Office in ShenZhen, R&D center in HangZhou, GMP factory in JiangSu.

Please note:All products which might have patent infringment are used for R&D only/ It's Not Senova's
responsibility in those markets where there are patent infringement regulated.









Senova means“Setp For Innovation", we are a professional company who's supplying APIs(mainly New Generics), 

Advanced Intermediates and KSM(Key Starting Materials) as well as technical Support/Registration support/Custom 

synthesis service in pharmaceutical and related field , we focus on serving those manufacturers' New Generics Projects 

from R&D stage to Commercial Stage from meterials to documents support(DMF/CMC). For those regulated markets,

we secure all of our products can be produced under GMP regulation with Full.Documentation.

Copyright Copyright (C) 2015-2035 Senova Technology Co. Ltd.
Address: 510# in Building 8 of North Area, Dayuan Industry Park, Xili, Nanshan District of Shenzhen,China 518055  Tel: +86-0755-8670 3119 QQ: 530953397 Email: info@senovatech.com